Cargando…
Identification of SARS-CoV-2 viral entry inhibitors using machine learning and cell-based pseudotyped particle assay
In response to the pandemic caused by SARS-CoV-2, we constructed a hybrid support vector machine (SVM) classification model using a set of publicly posted SARS-CoV-2 pseudotyped particle (PP) entry assay repurposing screen data to identify novel potent compounds as a starting point for drug developm...
Autores principales: | Sun, Hongmao, Wang, Yuhong, Chen, Catherine Z., Xu, Miao, Guo, Hui, Itkin, Misha, Zheng, Wei, Shen, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997310/ https://www.ncbi.nlm.nih.gov/pubmed/33831697 http://dx.doi.org/10.1016/j.bmc.2021.116119 |
Ejemplares similares
-
A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
por: Xu, Miao, et al.
Publicado: (2021) -
A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
por: Xu, Miao, et al.
Publicado: (2022) -
Identifying SARS-CoV-2 Entry Inhibitors through
Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped
Particles
por: Chen, Catherine Z., et al.
Publicado: (2020) -
Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles
por: Hsieh, Miao-Hsi, et al.
Publicado: (2021) -
Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
por: Condor Capcha, Jose Manuel, et al.
Publicado: (2021)